Morning Briefing
Summaries of health policy coverage from major news organizations
Viewpoints: Onlookers Have Made Up Their Minds About Cornell Sex Assault Case; 340B Policy Must Adapt For Drugs With Multiple Uses
USA Today: The 'Cornell 7' Haven't Been Charged. The Mob Doesn't Care
The heated reaction to the Cornell allegations and the rush to judge the young men involved before they’ve had their day in court makes me fear the country has learned nothing about the dangers of simply “believing women.” (Ingrid Jacques, 10/2)
The Guardian: The Horror Of The Cornell Rape Case Is How Ordinary It Is
Many men rape; many men giggle encouragingly, or shrug indifferently, when their friends rape. Many men rape, and few seem to think that it’s a very big deal. (Moira Donegan, 10/1)
Stat: Outdated 340B Policy On Orphan-Designated Drugs Must Be Fixed
As sure as the sun rises, Crohn’s disease is most definitely not juvenile idiopathic arthritis. But government policy doesn’t seem to understand that. (John Mildenberger, 10/2)
MedShadow Foundation: The FDA Is Negotiating With Drug Companies. Patient Safety Should Be Part Of The Deal
I went to D.C. to push for greater accountability and stronger safety protections for patients who rely on brand-name and generic drugs. (Suzanne B. Robotti, 10/1)
Stat: Marathons Need To Prepare Better For Extreme Heat
Though I have treated thousands of patients since, Nov. 6, 2022 — the day of a record hot New York City Marathon — still weighs on me. Around the three-and-a-half-hour mark of the race, the finish-line medical tent filled. Inside, I was volunteering as a medical provider and an amateur runner, assigned to a row of cots in the moderate-severity zone. The unseasonably climbing temperatures were taking a visible toll on athletes of all levels. (Vibhu Krishna, 10/2)
